Introduction: Increased levels of proinflammatory markers have been reported in tissues of individuals with Coronavirus Disease 2019 (COVID-19). We hypothesize that inflamed dental pulp tissues of individuals with previous history of COVID-19 may present a differential inflammatory gene expression profile in comparison with individuals who never had COVID-19.

Materials And Methods: Dental pulp tissues were collected from 27 individuals referred for endodontic treatment due to symptomatic irreversible pulpitis. Of these, 16 individuals had a history of COVID-19 (6 months to 1 year post infection) and 11 individuals had no previous history of COVID-19 (controls). Total RNA from pulp tissue samples was extracted and subjected to RNA sequencing for comparison of differentially expressed genes (DEGs) among groups. DEGs showing log2(fold change) > 1 or < -1, and P < .05 were considered significantly dysregulated.

Results: RNA sequencing identified 1461 genes as differentially expressed among the groups. Of these, 311 were protein coding genes, 252 (81%) that were upregulated and 59 (19%) that were downregulated in the COVID group compared with controls. The top upregulated genes in the COVID group were HSFX1 (4.12-fold change) and LINGO3 (2.06-fold change); significantly downregulated genes were LYZ (-1.52-fold change), CCL15 and IL8 (-1.45-fold change).

Conclusions: Differential gene expression in dental pulp tissues of COVID and non-COVID groups suggests potential contribution of COVID-19 on dysregulating inflammatory gene expression in the inflamed dental pulp.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174733PMC
http://dx.doi.org/10.1016/j.joen.2023.05.002DOI Listing

Publication Analysis

Top Keywords

history covid-19
16
dental pulp
12
pulp tissues
12
tissues individuals
12
differentially expressed
8
expressed genes
8
symptomatic irreversible
8
irreversible pulpitis
8
individuals previous
8
previous history
8

Similar Publications

The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting.

PLOS Glob Public Health

January 2025

Virginia G. Piper Center for Personalized Diagnostics, Biodesign Institute, Arizona State University, Tempe, Arizona, United States of America.

Omicron is the comparatively most transmissible and contagious variant of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). We conducted a seroprevalence study from March 1-3, 2022, to investigate the seroprevalence of SARS-CoV-2 antibodies among individuals aged 18 years and older after the Omicron outbreak. The seroprevalence of anti-receptor binding domain (RBD) antibodies was found to be 96.

View Article and Find Full Text PDF

Vaccines are one of the most important discoveries of humanity, being an effective intervention to protect the population against infectious diseases. When the Covid-19 vaccination campaign, the feat of Doctor Francisco Javier de Balmis y Berenguer in the Royal Philanthropic Vaccine Expedition is remembered due to the importance that vaccination has had over the years and mentioning that The National Vaccination Campaign against COVID-19 in Mexico began at the Dr. Eduardo Liceaga General Hospital of Mexico.

View Article and Find Full Text PDF

Background: Severe systemic infections can trigger cognitive decline, but the underlying mechanisms and their impact on the manifestation and progression of Alzheimer's disease and other neurodegenerative diseases are poorly understood. The current COVID-19 pandemic has brought a surge of severe viral illness and highlights the importance of understanding the impact of acute infections on cognition and the manifestation of neurodegenerative disease in survivors. A wealth of observational and clinical data suggests major short- and long-term effects of severe infections on cognition, but detailed and systematic analyses of neuropathological changes after acute infections are scarce.

View Article and Find Full Text PDF

Background: SARS CoV-2, neurotrophic virus in response to neuroinflammation causing varying cognitive deficits in post pandemic period. New onset rapidly progressive cognitive decline and deterioration in degenerative dementia has been seen in clinics in recent times. The paradigm shift of presentation of dementia needs detailed evaluation to facilitate further management.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Background: Smell dysfunction has been one of coronavirus disease 2019 (Covid-19) symptoms. Identification of those with these symptoms are important as olfactory impairment in general has been studied to have increased mortality, poor quality of life, increased incidence of depression and risk for dementia. Smell dysfunction related to Covid-19 in older adults and its impact is lesser studied.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!